Influenza Vaccine Market Intelligence Report - Global Forecast to 2027

Influenza Vaccine Market Intelligence Report - Global Forecast to 2027

The Global Influenza Vaccine Market is projected to reach USD 11,141.69 million by 2027 from USD 6,705.34 million in 2021, at a CAGR 8.83% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Influenza Vaccine Market size was estimated at USD 2,253.85 million in 2021 and expected to reach USD 2,457.08 million in 2022, at a CAGR 8.96% to reach USD 3,771.93 million by 2027.
• The Asia-Pacific Influenza Vaccine Market size was estimated at USD 1,874.81 million in 2021 and expected to reach USD 2,047.18 million in 2022, at a CAGR 9.02% to reach USD 3,148.36 million by 2027.
• The Europe, Middle East & Africa Influenza Vaccine Market size was estimated at USD 2,576.68 million in 2021 and expected to reach USD 2,781.08 million in 2022, at a CAGR 8.57% to reach USD 4,221.39 million by 2027.

Market Segmentation & Coverage:

The report on influenza vaccine identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the influenza vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Vaccine Type:

• Inactivated
• Live Attenuated
• Recombinant

Age Group:

• Adolescent Vaccination
• Adult Vaccination
• Infant Vaccination

Administration Route:

• Intramuscular
• Intranasal
• Oral

Distribution Channel:

• Government Medical Office
• Hospital & Clinic
• Retail Pharmacy
• Urgent Care Unit

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• AstraZeneca PLC
• Bayer AG
• BioDiem
• BiondVax Pharmaceuticals Ltd.
• Bristol-Myers Squibb Company
• CanSino Biologics Inc.
• Daiichi Sankyo Company, Limited
• Emergent BioSolutions Inc.
• Eurocept Group
• Fluart Innovative Vaccines Kft.
• Gamma Vaccines Pty Ltd
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi S.A.
• Seqirus GmbH
• Serum Institute of India Pvt. Ltd.
• Sinovac Biotech Ltd.
• Swedish Orphan Biovitrum AB